Companies

NRX Pharmaceuticals, Inc. (NRXP) SEC filings

CIK 0001719406 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)1.2 M
Net income (USD)-28.6 M-30.1 M-39.8 M
Diluted EPS (USD/shares)-0.6

Latest filings

FiledFormDescriptionPeriod
2026-10-168-KFORM 8-K items 8.01,9.012026-10-16
2026-10-058-KFORM 8-K items 1.01,9.012026-09-29
2026-09-168-KFORM 8-K items 8.01,9.012026-09-15
2026-09-148-KFORM 8-K items 7.01,9.012026-09-08
2026-08-178-KFORM 8-K items 2.02,9.012026-08-17
2026-08-1410-QFORM 10-Q2026-06-30
2026-08-078-KFORM 8-K items 7.012026-08-07
2026-07-228-KFORM 8-K items 8.012026-07-21
2026-06-048-KFORM 8-K items 1.01,8.01,9.012026-06-03
2026-06-03424B5FORM 424B5
2026-06-028-KFORM 8-K items 8.01,9.012026-06-02
2026-06-02424B5FORM 424B5
2026-05-2225-NSE25-NSE
2026-05-1510-QFORM 10-Q2026-03-31
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-03-248-KFORM 8-K items 5.02,5.07,9.012026-03-23
2026-03-2310-KFORM 10-K2025-12-31
2026-02-24DEFA14AFORM DEFA14A
2026-02-23ARSARS2024-12-31
2026-02-23DEF 14AFORM DEF 14A2026-03-23
2026-02-174FORM 42026-01-27
2026-02-173FORM 32026-01-27
2026-02-178-KFORM 8-K items 8.01,9.012026-02-17
2026-02-178-KFORM 8-K items 8.01,9.012026-02-17
2026-02-17424B5FORM 424B5

Forms on file (last 1,000): 8-K 131, 4 47, 424B3 44, 3 30, 10-Q 26, 424B5 15, CORRESP 15, DEF 14A 13. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=NRXP (0.002 USD), /gw/filings/filings?ticker=NRXP&form=8-K, /gw/filings/facts?ticker=NRXP&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange